The William Harvey Heart Centre was opened in 2011 by Sir William Castell LVO and is dedicated to tackling the growing burden of heart disease and stroke world-wide. The Centre is based at Queen Mary’s Charterhouse Square campus and represents a significant £25m investment that will provide a flow of innovative new therapies from the laboratory to the patients suffering from heart disease across north-east London and beyond.
The project was made possible by the incredible generosity and support of the late Clive Priestley CB and the Trustees of the Medical College of St Bartholomew’s Hospital Trust who worked very closely with Professor Mark Caulfield to bring the Centre to life. A major attribute of the Heart Centre is the integration of laboratory work with patient engagement alongside a state of the art and Clinical Trials Unit, which can run clinical studies in multiple therapeutic areas specialising in but not limited to cardiovascular, respiratory, endocrinology and rheumatology diseases.
The Heart Centre forms part of the Barts and The London Cardiovascular Biomedical Research Unit and is specifically designed to provide the cardiovascular research hub for the £400m rebuild of St Bartholomew’s Hospital which opened in 2014. Our ethnically diverse east London community suffer appalling rates of heart disease, possibly due to undiscovered risk factors that may offer the basis for new treatments – we are therefore uniquely placed to act as a research window for these communities from emergent nations across the world. Our strategic focus on translational therapeutic innovation will ensure that the William Harvey Heart Centre competes with the best in the world, addressing areas of important unmet need with global healthcare implications.